Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin + 5-FU in advanced head and neck cancer
NCT00611754Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sanofi. Started May 2000; status: completed.
02
Drugs
oxaliplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00611754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611754.